Holders — by stockHoldings — by fund
First Turn Management, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001993440
$753.0M
disclosed book value
38
positions
5.8%
largest position share
Positions, as of 2026-09-30
top 38 of 38 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | ELVNENLIVEN THERAPEUTICS INC | 958,700 | $43.9M | 5.8% |
| 2 | GHGUARDANT HEALTH INC | 219,304 | $39.1M | 5.2% |
| 3 | ABVXABIVAX SA | 384,592 | $38.1M | 5.1% |
| 4 | ROIVROIVANT SCIENCES LTD | 985,583 | $36.0M | 4.8% |
| 5 | UTHRUNITED THERAPEUTICS CORP DEL | 60,064 | $32.5M | 4.3% |
| 6 | VRDNVIRIDIAN THERAPEUTICS INC | 1.5M | $31.4M | 4.2% |
| 7 | AXSMAXSOME THERAPEUTICS INC. | 162,407 | $29.9M | 4% |
| 8 | INSMINSMED INC | 245,726 | $28.0M | 3.7% |
| 9 | CELCCELCUITY INC | 329,101 | $26.2M | 3.5% |
| 10 | CRLCHARLES RIV LABS INTL INC | 86,801 | $25.6M | 3.4% |
| 11 | CYTKCYTOKINETICS INC | 357,945 | $23.6M | 3.1% |
| 12 | BBIOBRIDGEBIO PHARMA INC | 354,371 | $23.3M | 3.1% |
| 13 | PRAXPRAXIS PRECISION MEDICINES I | 78,806 | $23.0M | 3% |
| 14 | ORICORIC PHARMACEUTICALS INC | 1.6M | $21.2M | 2.8% |
| 15 | RGENREPLIGEN CORP | 108,436 | $20.8M | 2.8% |
| 16 | TNGXTANGO THERAPEUTICS INC | 766,860 | $19.1M | 2.5% |
| 17 | RVMDREVOLUTION MEDICINES INC | 92,316 | $18.9M | 2.5% |
| 18 | INBXINHIBRX BIOSCIENCES INC | 171,512 | $17.2M | 2.3% |
| 19 | NAMSNEWAMSTERDAM PHARMA COMPANY | 702,396 | $17.1M | 2.3% |
| 20 | MANEVERADERMICS INC | 136,718 | $16.6M | 2.2% |
| 21 | COGTCOGENT BIOSCIENCES INC | 514,976 | $16.5M | 2.2% |
| 22 | DNTHDIANTHUS THERAPEUTICS INC | 178,573 | $15.7M | 2.1% |
| 23 | PVLAPALVELLA THERAPEUTICS INC NE | 109,871 | $15.2M | 2% |
| 24 | RYTMRHYTHM PHARMACEUTICALS INC | 157,603 | $15.0M | 2% |
| 25 | RCUSARCUS BIOSCIENCES INC | 577,693 | $14.9M | 2% |
| 26 | ARWRARROWHEAD PHARMACEUTICALS IN | 222,649 | $14.6M | 1.9% |
| 27 | IRONDISC MEDICINE INC | 220,666 | $14.4M | 1.9% |
| 28 | ERASERASCA INC | 913,452 | $13.4M | 1.8% |
| 29 | GRALGRAIL INC | 93,727 | $13.1M | 1.7% |
| 30 | KYMRKYMERA THERAPEUTICS INC | 113,299 | $12.7M | 1.7% |
| 31 | ASNDASCENDIS PHARMA A/S | 54,594 | $12.4M | 1.7% |
| 32 | QUREUNIQURE NV | 465,474 | $11.2M | 1.5% |
| 33 | XENEXENON PHARMACEUTICALS INC | 297,060 | $11.0M | 1.5% |
| 34 | SYRESPYRE THERAPEUTICS INC | 102,541 | $9.1M | 1.2% |
| 35 | SMMTSUMMIT THERAPEUTICS INC | 501,724 | $8.5M | 1.1% |
| 36 | DFTXDEFINIUM THERAPEUTICS INC | 216,531 | $8.2M | 1.1% |
| 37 | PCVXVAXCYTE INC | 137,534 | $7.8M | 1% |
| 38 | HNGEHINGE HEALTH INC | 75,448 | $7.3M | 1% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.